MF
NVO

Manchester Financial’s Novo Nordisk NVO Stock Holding History

Manchester Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-198
Closed -$7K – 453
2021
Q1 		$7K Hold
198
– – ﹤0.01% 488
2020
Q4 		$7K Hold
198
– – ﹤0.01% 414
2020
Q3 		$7K Hold
198
– – 0.01% 354
2020
Q2 		$6K Hold
198
– – ﹤0.01% 359
2020
Q1 		$6K Sell
198
-714
-78% -$21.3K ﹤0.01% 331
2019
Q4 		$26K Buy
+912
New +$25.3K 0.01% 227

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Manchester Financial's NVO Position: Q2 2021 in Review

Manchester Financial sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 198 shares — an estimated $7K sold.

Manchester Financial first reported a position in NVO in Q4 2019 and held it in 6 quarters. The position peaked at $26K in Q4 2019. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Manchester Financial reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 198 Novo Nordisk shares in Q2 2021, an estimated $7K.
  • Manchester Financial first reported a position in Novo Nordisk in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Novo Nordisk position peaked at $26K in Q4 2019.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.